In the second part of our interview with the esteemed Professor Thomas Borody from Australia, we discuss the question of ethical clinical trials, the progress in Australia with the Ivermectin-based tri-therapy he recommends for COVID-19, the role of State and federal authories.
We treat them for 10 days using an appropriate dose of ivermectin, doxycycline daily and zinc daily.
They all actually have activity against the intracellular multiplication of the virus and from published data you can read that most of the results have been close to 100 percent cure there was one that used the lower level and got 92 percent cure but it’s just hard to believe how simple it is to cure coronavirus.
One such drug is ivermectin, a safe medicine which has been used for nearly 40 years to treat parasitic infections. New evidence show that it has
The DEPUTY SPEAKER: I don’t think there is room for debate about the issues that the member for Hughes is raising. He’s entitled to put his point of view. He’s as relevant as I suspect he is going to be. I’d like him to continue.
In El Salvador, the Ministry of Public Health has embraced Ivermectin as part of a combination of recommendations for early treatment of COVID-19
We are pleased to present a webinar about a crucial topic: the early treatment of those catching COVID-19, especially with the Delta variant. The Delta, which represents the vast majority of new cases in the US and many other countries, requires indeed a slightly different approach for its early treatment.
We are pleased to present a webinar about a crucial topic: the early treatment of those catching COVID-19, especially with the Delta variant.
Dr. Richard Urso is a medical doctor and scientist who invented an FDA approved wound healing drug. With a background in drug development, he has been advocate for early treatment since March 2020. He’s appeared on over 60 media outlets including Laura Ingraham, Charlie Kirk, and C span. He’s met with leaders of the Covid task force such as Vice President Pence, Deborah Birx, leaders of the Congress, Senate and CDC. He’s played a prominent role in Covid awareness in Texas, meeting with members of the Governor’s office and testifying before the Texas Senate.
There are a number of protocols (sets of prescription and/or OTC meds) for COVID-19. There are prophylactic protocols, which reduce risk of infection. There are sick-at-home protocols, for the milder cases. And there are in-hospital protocols, for the more severe cases.
Risk and benefit analysis suggests if a drug with a well-established, safe profile can help then why wouldn’t such a drug be used?
The latest information about:
the Delta variant;
asymptomatic transmission and testing;
natural immunity from having a covid-19 infection vs vaccination;
what to do if you have symptoms;
testing;
the use of nutraceuticals;
treatment protocols;
the use of hydroxychloroquine and ivermectin;
putting to rest the question of hydroxychloroquine and adverse cardiological effects;
gastrointestinal symptoms of Delta;
being aware of our state of health;
oral and dental hygiene;
the use of monoclonal antibodies including Regeneron, Remdesivir and full dose blood thinners;
outpatient followup;
long hauler Covid;
myocarditis;
the commencement of early treatment;
the role of fever in the disease process;
the use of NSAIDs;
obesity as a risk factor;
talking to your physician;
the failure of vaccines.
Dr Stramezzi talks about his experience, his perspectives on treatment of Covid-19, his telemedicine service & the upcoming International Covid Summit in Rome in September.
An in-depth interview with Dr. Tess Lawrie of EBMC Squared describing the effectiveness of long-time safe medicine ivermectin to treat and prevent covid and how health authorities are systematically ignoring the evidence.
In Dr. Ozaki’s recent speech, he declared that ivermectin has demonstrated significant benefits in reducing infections and deaths where the regimen is prophylactically administered for another indication. The head of the Metropolitan Medical Association declared that while clinical trials were important, it was time to greenlight doctors to prescribe ivermectin in association with giving the patient informed consent.
Just as Galileo proved with his telescope that the earth was NOT the center of the Universe in 1616; today, the data from India shows that Ivermectin is effective, much more so than the vaccines. It not only prevents death, but it also prevents COVID infections, and it also is effective against the Delta Variant.
This is a far reaching interview with Nick Hudson, who is the leader of PANDA, which stands for Pandemics Data & Analytics
This interview with Steve Kirsch features early treatment, vaccination, government responses to pandemics, tech companies & freedom of expression.
Two doses (300 μg/kg/dose in a gap of 72 hours) of ivermectin chemoprophylaxis reduced COVID-19 infection by 83% among HCWs for one month. Ivermectin is a safe and effective strategy to prevent COVID-19, in the containment of pandemic alongside vaccine. Further research is required to guide the frequency of chemoprevention, acceptability, and cost-effectiveness in the community setting.
Over the past four months, E-BMC Ltd has been working together with the FLCCC to encourage governments around the world to adopt re-purposed existing drugs for the early treatment of
covid-19. One such drug is Ivermectin, a safe medicine which has been used for nearly 40 years to treat parasitic infections. properties as well. E-BMC Ltd’s comprehensive meta-analysis, which has now been published in the peer-reviewed American Journal of Therapeutics, shows that “moderate-certainty evidence” points to a substantial reduction in Covid-19 related deaths with the use of ivermectin.
Dr George Fareed provides an update about the outpatient treatment of COVID-19, for newly infected and for long covid patients.
Borody’s ivermectin triple therapy prophylactic is the perfect solution. It reduces transmission immediately, regardless of the variant, by preventing the virus from entering a person’s cells. It also shortens time spent in quarantine and reduces transmission to close contacts. Early treatment dramatically reduces hospitalisation and mortality and would rapidly end the Sydney wave, as similar therapies did in Mexico and India. It would also put an end to any need for masks and lockdowns.
The heated debate on the use of Ivermectin to treat COVID-19 continued yesterday when outspoken reggae artiste Tanya Stephens questioned the relevance of not allowing people to decide for themselves what they wish to take to reduce symptoms.
Dr. Safranek aligns his message with groups such as the Front Line COVID-19 Critical Care Alliance (FLCCC) who emphasize the early-onset treatment of the viral disease can make a difference between life and death.
Jamaica’s Minister of Health and Wellness recently signed the import permit to allow stocks of Ivermectin into Jamaica. This comes after rising cases due to the COVID-19 Delta variant and increasing public pressure. Supplies of the generic, anti-parasitic drug will come from Edenbridge Pharmaceuticals in New Jersey and be distributed by LASCO Pharmaceuticals in Jamaica. In general, doctors are pleased about having Ivermectin as an option.
It’s all so cruel and unnecessary. With or without Professor Skerritt, if doctors prescribed ivermectin therapy for every person who tests positive, and wants it, and for their close contacts, the Delta wave would wash away. Offer it to the vaccine-hesitant and anyone seeking protection until they were vaccinated, and we could reopen our borders. How apposite that the escape route out of our pandemic prison could be as Aussie as Vegemite.
We believe that the Medical Products Agency should follow the example of the Czech Republic, Slovakia and several other countries and approve ivermectin as treatment for covid-19
This interview features Dr Caxton Opere, who has not only treated C19 patients but also written 3 books about it, the first one in early April 2020.
Altogether, this study brings the proof of concept that an IVM-based immunomodulatory therapy improves the clinical condition of SARS-CoV-2-infected hamsters, and in clinical trials, it alleviates symptoms of COVID-19 in humans and possibly limits post-COVID-19 syndrome (also known as long COVID) via an anti-inflammatory action.
Dr. Vladimir Zelenko talks with author John Leake about treating his patients for Covid-19 and then sharing his insight with the White House. In spite of (or because of) President Trump’s initial embrace of Dr. Zelenko’s treatment protocol, government agencies such as the NIH and FDA first dismissed it, and then prevented public access to its key ingredient, hydroxychloroquine. This deliberate suppression of a life saving medication led to the preventable deaths of hundreds of thousands of Americans.
The data from the vaccine trials must be recalculated under the lens that some of the serious adverse events (SAEs) should be treated as COVID-19 cases.
There may not be any vaccine efficacy in the data at all if some of the post-vaccination deaths are due to vaccine-induced COVID-19. It could even be the case that the mortality efficacy goes negative. My implied lives saved calculations put this easily in the realm of possibility. The only way to know is for authorities to organize and compile the data. And while a risk analysis is certainly due after more than six months of hundreds of millions of doses delivered, there is little indication authorities have bothered with the process. That’s more than a bit unsettling.
We continue to delve extensively into the COVID-19 data with esteemed statistician, Mathew Crawford. In this episode, we take a closer look at the use of early treatment and its success. Mathew has been researching the data from Dr. Brian Tyson, who has successfully treated over 6000 patients who contracted COVID throughout the pandemic. It is my great honor to have Dr. Tyson here on this episode to not only discuss the data, but also the strategies that he has been using throughout the pandemic.
The Roman/Hernandez meta-analysis comes at a politically contentious moment. Their language and behavior appear political. Their work is error-laden, takes research out of its true context, uses numbers that don’t seem to come from the actual studies, chooses papers testing ivermectin under the least favorable circumstances, gives unexplained and inappropriate weights to the small amount of data that stands as outliers to the bigger picture, and still drives a conclusion of “don’t use this” from a massive average mortality reduction that did not quite reach statistical significance. At the same time the authors consistently complain about the “low quality of evidence” represented by the studies they do and do not include, nearly all of which I would describe as produced by higher quality scientists who can at least tally numbers correctly.
Those who design the trials and control the data also control the outcome. So this system of industry-led trials needs to be put to an end.
The death rate from COVID-19 is dramatically low at United Memorial Medical Center in Houston, TX compared to other hospitals across the nation and the world. Despite Dr. Joseph Varon’s popularity on TV, news personalities avoid questions of why he’s having success treating his patients. As it turns out, he’s using drugs the WHO and CDC recommend against.
Dr. Risch gives a succinct history of the politics of hydroxychloroquine and other useful existing medicines in the USA, which has had global effect, as many countries look to the USA for guidance. Corruption and manipulation from behind the scenes around the world are brought to the surface for scrutiny.
For months, India’s national authorities have authorized ivermectin as a regimen to be included targeting COVID-19 yet this authorization was then removed due in part to both internal and external political pressure. Now the world’s fourth most populous nation’s regulatory authority has authorised ivermectin’s use in a major breakthrough for the drug’s role in the COVID-19 pandemic.
Oxford University is going to investigate the effectiveness of ivermectin as a COVID-19 treatment. Emeritus Professor Robert Clancy, an immunologist at the University of Newcastle, tells Paul Turton that he believes they’ll find the drug useful, and that it will become part of our coronavirus response.
Source: Rounding The Earth Author: Mathew Crawford Since sometime last summer, I’ve paid (increasing) attention to much of the rapidly growing body of evidence that ivermectin (IVM)
Pointing out the drug’s safety, this German physician suggested that where ivermectin (Driponin in Germany) is in use, the incidence of COVID-19 goes down.
Large reductions in Covid-19 deaths are possible using ivermectin.
Using ivermectin early may reduce the numbers progressing to severe disease.
Ivermectin is low cost.
